Garden State Investment Advisory Services’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
Garden State Investment Advisory Services's PFE Position: Q2 2026 in Review
Garden State Investment Advisory Services increased its Pfizer (PFE) stake by 6% in Q2 2026, buying an estimated $30.3K and bringing the position to 20,511 shares worth $494K. The position accounts for 0.09% of the portfolio, ranked #177.
Garden State Investment Advisory Services first reported a position in PFE in Q4 2022 and has held it in 15 quarters since. The position peaked at $718K in Q2 2025. 2,239 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- Garden State Investment Advisory Services held 20,511 shares of Pfizer worth $494K as of Q2 2026.
- Garden State Investment Advisory Services bought 1,158 Pfizer shares in Q2 2026, an estimated $30.3K.
- Pfizer made up 0.09% of Garden State Investment Advisory Services's portfolio in Q2 2026, its #177 holding.
- Garden State Investment Advisory Services first reported a position in Pfizer in Q4 2022 and has held it in 15 quarters since.
- Garden State Investment Advisory Services's Pfizer position peaked at $718K in Q2 2025.
- 2,239 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on Garden State Investment Advisory Services's 13F filing for Q2 2026, filed 11 Aug 2026.